<< Back
Price to Revenue (TTM)
This is the current Price divided by the Sales Per Share for the trailing twelve months. If there is a preliminary earnings announcement for an interim period that has recently ended, the revenue (sales) values from this announcement will be used in calculating the trailing twelve month revenue per share.
NASDAQ (US Dollar)
$69.20
 Stock is Down 0.58 (0.83%)
Data as of 11/16/18 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Third Quarter 2018 Gilead Sciences Earnings Conference Call

October 25, 2018 4:30 p.m. ET
Play
Gilead Sciences at the Morgan Stanley 16th Annual Global Healthcare Conference

September 12, 2018 11:05 a.m. ET
Play
Second Quarter 2018 Gilead Sciences Earnings Conference Call

July 25, 2018 2:00 p.m. PT
Play
Gilead Sciences at the Goldman Sachs 39th Annual Global Healthcare Conference

June 13, 2018 8:40 a.m. PT
Play